Renaissance Technologies
QNTM

Renaissance Technologies’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Renaissance Technologies’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,697
Closed -$49.5K – 3961
2024
Q2 		$49.5K Buy
4,697
+3,539
+306% +$86.3K ﹤0.01% 3293
2024
Q1 		$54K Buy
1,158
+93
+9% +$5.1K ﹤0.01% 3476
2023
Q4 		$64K Buy
1,065
+10
+0.9% +$704 ﹤0.01% 3408
2023
Q3 		$83K Sell
1,055
-523
-33% -$42.7K ﹤0.01% 3291
2023
Q2 		$118K Buy
1,578
+516
+49% +$44.3K ﹤0.01% 3434
2023
Q1 		$107K Buy
1,062
+151
+17% +$13K ﹤0.01% 3474
2022
Q4 		$47K Sell
911
-7
-0.8% -$387 ﹤0.01% 3810
2022
Q3 		$49K Buy
918
+13
+1% +$763 ﹤0.01% 3766
2022
Q2 		$46K Buy
905
+403
+80% +$24.2K ﹤0.01% 4010
2022
Q1 		$28K Buy
502
+297
+145% +$18K ﹤0.01% 3978
2021
Q4 		$14K Buy
+205
New +$17.8K ﹤0.01% 3851
2021
Q1 		– Sell
-710
Closed -$72K – 3781
2020
Q4 		$72K Buy
+710
New +$83.8K ﹤0.01% 3295

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's QNTM Position: Q3 2024 in Review

Renaissance Technologies sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2024, closing a stake of 4,697 shares — an estimated $49.5K sold.

Renaissance Technologies first reported a position in QNTM in Q4 2020 and held it in 12 quarters. The position peaked at $118K in Q2 2023. 12 funds tracked by Wall St. Rank hold QNTM as of Q3 2024.

  • Renaissance Technologies reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2024 after selling out during the quarter.
  • Renaissance Technologies sold 4,697 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2024, an estimated $49.5K.
  • Renaissance Technologies first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2020 and held it in 12 quarters.
  • Renaissance Technologies's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $118K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.